We are live on ! Find out more
CCXI

ChemoCentryx, Inc.
CCXI

Delisted

CCXI was delisted on the 19th of October, 2022.

Back to rankings

1 hedge funds and large institutions have $52 invested in ChemoCentryx, Inc. in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 212 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 217 → 1 (-216)

100% less funds holding in top 10

Funds holding in top 10: 12 → 0 (-12)

100% less capital invested

Capital invested by funds: $3.2B → $52 (-$3.2B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 212

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-216
Holders Change %
-99.54%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
212
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$311M
2
Goldman Sachs
Goldman Sachs
New York
-$290M
3
BlackRock
BlackRock
New York
-$250M
4
UOC
UBS O'Connor
Illinois
-$141M
5
State Street
State Street
Massachusetts
-$140M
Name Holding Trade Value Shares
Change 		Change in
Stake
WP
51
Woodline Partners
California
– -$13.8M -267,540 Closed
Janus Henderson Group
52
Janus Henderson Group
United Kingdom
– -$13.7M -265,478 Closed
BCM
53
Beryl Capital Management
California
– -$12.9M -250,000 Closed
Wellington Management Group
54
Wellington Management Group
Massachusetts
– -$12.9M -248,943 Closed
NYLIM
55
New York Life Investment Management
New York
– -$12.6M -243,522 Closed
JP Morgan Chase
56
JP Morgan Chase
New York
– -$10.9M -211,078 Closed
State of Wisconsin Investment Board
57
State of Wisconsin Investment Board
Wisconsin
– -$10.8M -209,221 Closed
PCM
58
Prelude Capital Management
New York
– -$10.8M -208,861 Closed
PA
59
Perceptive Advisors
New York
– -$9.95M -192,680 Closed
HF
60
HRT Financial
New York
– -$9.94M -192,459 Closed
OAC
61
OMERS Administration Corp
Ontario, Canada
– -$9.04M -174,900 Closed
ACM
62
Altium Capital Management
New York
– -$8.27M -160,000 Closed
National Bank of Canada
63
National Bank of Canada
Quebec, Canada
– -$7.75M -150,000 Closed
CCM
64
Crabel Capital Management
California
– -$7.68M -148,692 Closed
WCMNY
65
Westchester Capital Management (New York)
New York
– -$7.63M -147,664 Closed
Citigroup
66
Citigroup
New York
– -$7.29M -141,170 Closed
Swiss National Bank
67
Swiss National Bank
Switzerland
– -$6.98M -135,100 Closed
Rafferty Asset Management
68
Rafferty Asset Management
New York
– -$6.95M -134,596 Closed
CS
69
Credit Suisse
Switzerland
– -$6.62M -128,181 Closed
Lord, Abbett & Co
70
Lord, Abbett & Co
New Jersey
– -$6.05M -117,152 Closed
Barclays
71
Barclays
United Kingdom
– -$6M -116,113 Closed
UBS Group
72
UBS Group
Switzerland
– -$5.97M -115,482 Closed
Citadel Advisors
73
Citadel Advisors
Florida
– -$5.84M -112,981 Closed
Arrowstreet Capital
74
Arrowstreet Capital
Massachusetts
– -$5.52M -106,862 Closed
Dimensional Fund Advisors
75
Dimensional Fund Advisors
Texas
– -$5.2M -100,626 Closed
1 2
3
4 5

CCXI Hedge Fund Activity: Q4 2022 in Review

1 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2022, worth a combined $52 — down 100% from $3.2B a quarter earlier.

Sellers outnumbered buyers: 212 funds closed out of CCXI and 0 opened new positions — a net loss of 212 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $311M sold.

  • 1 institutional investor held ChemoCentryx, Inc. (CCXI) as of Q4 2022, down from 217 in Q3 2022.
  • Funds reported $52 of ChemoCentryx, Inc. stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new ChemoCentryx, Inc. positions in Q4 2022 and 212 closed out, a net change of -212 holders.
  • The largest ChemoCentryx, Inc. seller in Q4 2022 was Vanguard Group, an estimated $311M sold.

Based on aggregated 13F filings for Q4 2022.